Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 3 , Pages 383-387 , June 2008

Does Continuous Insulin Therapy Reduce Postoperative Supraventricular Tachycardia Incidence After Coronary Artery Bypass Operations in Diabetic Patients?

  • Pakize Kirdemir, MD, FIPP

      Affiliations

    • Department of Anesthesiology, University of Suleyman Demirel, Isparta, Turkey
    • Corresponding Author InformationAddress reprint requests to Pakize Kirdemir, 1001 Evler 4780 Sokak, No 29, Isparta, Turkey.
    • ,
  • Vedat Yildirim, MD

      Affiliations

    • Department of Anesthesiology, Gulhane Military Medical Academy, Isparta, Turkey
    • ,
  • Ilker Kiris, MD

      Affiliations

    • Department of Cardiovascular Surgery, University of Suleyman Demirel, Isparta, Turkey
    • ,
  • Senol Gulmen, MD

      Affiliations

    • Department of Cardiovascular Surgery, University of Suleyman Demirel, Isparta, Turkey
    • ,
  • Erkan Kuralay, MD

      Affiliations

    • Department of Cardiovascular Surgery, University of Suleyman Demirel, Isparta, Turkey
    • ,
  • Erdogan Ibrisim, MD

      Affiliations

    • Department of Cardiovascular Surgery, University of Suleyman Demirel, Isparta, Turkey
    • ,
  • Ertugrul Ozal, MD

      Affiliations

    • Department of Cardiovascular Surgery, Gulhane Military Medical Academy, Ankara, Turkey.

References 

  1. Cosgrove DM, Loop FD, Lytle BW, et al. Determinants of 10-year survival after primary myocardial revascularization. Ann Surg. 1985;202:480–490
  2. Lawrie GM, Morris GC, Glaeser DH. Influence of diabetes mellitus on the results of coronary bypass surgery: Follow-up of 212 diabetic patients ten to 15 years after surgery. JAMA. 1986;256:2967–2971
  3. Herlitz J, Wognsen GB, Emanuelsson H, et al. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care. 1996;19:698–703
  4. Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1996;67:1045–1052
  5. Carson JL, Scholz PM, Chen AY, et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:418–423
  6. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356–361
  7. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352–360
  8. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Surg. 2003;125:1007–1021
  9. Yilmaz AT, Demirkilic U, Arslan M, et al. Long-term prevention of atrial fibrillation after coronary artery bypass surgery: Comparison of quinidine, verapamil and amiodarone in maintaining sinus rhythm. J Card Surg. 1996;11:61–64
  10. Tyras DH, Stothert JC, Kaiser GL, et al. Supraventricular tachyarrhythmias after coronary artery revascularization (A randomized trial of prophylactic digitalization). J Thorac Cardiovasc Surg. 1979;77:310–314
  11. Kuralay E, Cingöz F, Kilic S, et al. Supraventricular tachyarrythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial). Eur J Cardiothorac Surg. 2004;25:224–230
  12. Borzak S, Tisdale JE, Amin NB, et al. Atrial fibrillation after bypass surgery (Does the arrhythmia or characteristics of the patients prolong hospital stay?). Chest. 1998;113:1489–1491
  13. Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery (A major morbid event). Ann Surg. 1997;226:501–513
  14. Tull D, Albawn GS. Appendix I. Survey Research: A Decisional Approach. In: New York: Intext Press Inc; 1973;p. 225
  15. Gordis L. Epidemiology, in Randomized Trails: Some Further Issues. In: ed 2. London: WB Saunders; 1996;p. 110–115
  16. Abel RM, VanGelder HM, Pores IH, et al. Continued propranolol administration following coronary bypass surgery. Arch Surg. 1983;118:727–731
  17. Iwey MF, lwey TD, Bailey WW, et al. Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization (A randomized trial). J Thorac Cardiovasc Surg. 1983;85:214–218
  18. Roffman JA, Fielman A. Digoxin and propranolol in the prophylaxis of supraventricular tachydysrhythmias after coronary artery bypass. Ann Thorac Surg. 1981;31:496–500
  19. Taegtmeyer H. Carbohydrate interconversions and energy production. Circulation. 1985;72:IV1–IV8
  20. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem. 1991;266:8162–8170
  21. Rao V, Merante F, Weisel RD, et al. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. J Thorac Cardiovasc Surg. 1998;116:485–494
  22. Lazar HL, Zhang X, Rivers S, et al. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg. 1995;60:411–416
  23. Lazar HL. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions. J Card Surg. 1994;9(suppl):474–478
  24. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497–1502

PII: S1053-0770(07)00291-1

doi: 10.1053/j.jvca.2007.09.015

Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 3 , Pages 383-387 , June 2008

Article Tools